• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Opthea Ltd ADR (NQ: OPT )

    3.325 UNCHANGED
    Streaming Delayed Price Updated: 3:09 PM EDT, Sep 16, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.325
    Bid (Size) 3.130 (1)
    Ask (Size) 5.320 (2)
    Prev. Close 3.325
    Today's Range 3.325 - 3.325
    52wk Range 1.600 - 4.400
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    7 Growth Stocks to Buy to Outperform the Nasdaq Index
    These seven high-growth stocks across various sectors have the potential to outperform the tech-heavy Nasdaq over the long-run. 
    Via InvestorPlace

    Performance

    YTD
    +11.20%
    +11.20%
    1 Month
    +21.35%
    +21.35%
    3 Month
    +75.94%
    +75.94%
    6 Month
    -1.92%
    -1.92%
    1 Year
    +75.00%
    +75.00%

    More News

    Read More
    Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Why Is Retinal Diseases-Focused Opthea Stock Trading Higher Today?
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Opthea to Receive US$35M Commitment and Additional US$50M Funding
    From Opthea Limited
    Via GlobeNewswire
    Opthea Receives A$8.8 million R&D Tax Incentive
    From Opthea Limited
    Via GlobeNewswire
    Opthea to Present at the FLORetina 2023 Congress
    From Opthea Limited
    Via GlobeNewswire
    Opthea to Present at the Jefferies 2023 London Healthcare Conference
    From Opthea Limited
    Via GlobeNewswire
    Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
    From Opthea Limited
    Via GlobeNewswire
    Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
    From Opthea Limited
    Via GlobeNewswire
    Opthea to Participate at the 2023 Euretina Congress
    From Opthea Limited
    Via GlobeNewswire
    Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    From Opthea Limited
    Via GlobeNewswire
    Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)
    From Opthea Limited
    Via GlobeNewswire
    Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302
    From Opthea Limited
    Via GlobeNewswire
    Opthea to Present at the 2023 Ophthalmology Innovation Summit
    From Opthea Limited
    Via GlobeNewswire
    Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting
    From Opthea Limited
    Via GlobeNewswire
    Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor
    From Opthea Limited
    Via GlobeNewswire
    Opthea Appoints Anshul Thakral as Non-Executive Director of the Board
    From Opthea Limited
    Via GlobeNewswire
    Opthea to Present at the Jefferies 2023 Healthcare Conference
    From Opthea Limited
    Via GlobeNewswire
    Opthea to Participate in EF Hutton Hosted Discussion on OPT-302 and the Wet AMD Market
    From Opthea Limited
    Via GlobeNewswire
    Opthea To Present at the JMP Securities Life Sciences Conference
    From Opthea Limited
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.